{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The orexin‐1 receptor (HCRTR1) plays a multifaceted role in both central and peripheral systems by integrating neuroendocrine, metabolic, mood‐related, and cell fate signals. For example, HCRTR1 activation by orexin‐A promotes arousal as well as feeding and reward processing. In heterologous systems, interactions between HCRTR1 and other G protein–coupled receptors—notably cannabinoid CB1 receptors—enhance intracellular signaling cascades that modulate energy homeostasis and motivational behavior."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the realm of stress and addiction, genetic deletion or pharmacologic blockade of HCRTR1 with antagonists such as SB334867 has been shown to attenuate nicotine‐induced anxiogenic responses and reduce behavioral despair—findings that underscore HCRTR1’s importance in mediating mood and negative affective states."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Structural studies have further elucidated critical ligand-binding domains of HCRTR1 that are essential for orexin-A activation, while at the cellular level, receptor activation can trigger apoptotic cascades through specific tyrosine-based motifs (ITIM/ITSM). These mechanisms point to HCRTR1’s potential as a therapeutic target in certain cancer types."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In endocrine tissues, HCRTR1 signaling is critical for the stimulation of glucocorticoid secretion from adrenocortical cells via a cyclic AMP/protein kinase A pathway, thereby contributing to the regulation of steroidogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, genetic studies have uncovered associations between HCRTR1 gene variants and susceptibility to major mood disorders, migraine, and even alterations in water balance in psychiatric populations, suggesting that receptor polymorphisms may influence disease risk and symptom severity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, emerging evidence indicates that accessory proteins (e.g., MRAP2) and receptor heteromerization—such as between HCRTR1 and CB1—can fine-tune HCRTR1 trafficking and signaling, adding another level of modulation to its roles in energy metabolism and reward-related behaviors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings demonstrate that HCRTR1 is a pivotal molecular integrator that modulates arousal, reward, mood, endocrine function, and apoptotic pathways, making it a promising target for therapeutic intervention in disorders ranging from addiction and depression to endocrine dysfunction and cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sandrine Hilairet, Monsif Bouaboula, Dominique Carrière, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M212369200"}], "href": "https://doi.org/10.1074/jbc.M212369200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12690115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12690115"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ruth Sharf, Maysa Sarhan, Catherine E Brayton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2009.12.035"}], "href": "https://doi.org/10.1016/j.biopsych.2009.12.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20189166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20189166"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "África Flores, Rafael Maldonado, Fernando Berrendero "}, {"type": "b", "children": [{"type": "t", "text": "The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2013.06.012"}], "href": "https://doi.org/10.1016/j.biopsych.2013.06.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23896204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23896204"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ainhoa Plaza-Zabala, Elena Martín-García, Luis de Lecea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.5724-09.2010"}], "href": "https://doi.org/10.1523/JNEUROSCI.5724-09.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20147556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20147556"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Michael M Scott, Jacob N Marcus, Ami Pettersen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hcrtr1 and 2 signaling differentially regulates depression-like behaviors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Behav Brain Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbr.2011.02.044"}], "href": "https://doi.org/10.1016/j.bbr.2011.02.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21377495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21377495"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jie Yin, Kerim Babaoglu, Chad A Brautigam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.3183"}], "href": "https://doi.org/10.1038/nsmb.3183"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26950369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26950369"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Sylwia Ammoun, Dan Lindholm, Hanna Wootz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M508603200"}], "href": "https://doi.org/10.1074/jbc.M508603200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16282319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16282319"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Thierry Voisin, Aadil El Firar, Christiane Rouyer-Fessard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.07-098723"}], "href": "https://doi.org/10.1096/fj.07-098723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18198212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18198212"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "R Spinazzi, M Rucinski, G Neri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2004-2385"}], "href": "https://doi.org/10.1210/jc.2004-2385"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15797953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15797953"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Innocenzo Rainero, Luca Ostacoli, Elisa Rubino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between major mood disorders and the hypocretin receptor 1 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Affect Disord (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jad.2010.10.033"}], "href": "https://doi.org/10.1016/j.jad.2010.10.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21071097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21071097"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Innocenzo Rainero, Elisa Rubino, Salvatore Gallone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for an association between migraine and the hypocretin receptor 1 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Headache Pain (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10194-011-0314-8"}], "href": "https://doi.org/10.1007/s10194-011-0314-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21344296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21344296"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Joanne Meerabux, Yoshimi Iwayama, Takeshi Sakurai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2005.04.015"}], "href": "https://doi.org/10.1016/j.biopsych.2005.04.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15978554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15978554"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Maria H Jäntti, Ilona Mandrika, Jyrki P Kukkonen "}, {"type": "b", "children": [{"type": "t", "text": "Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.02.026"}], "href": "https://doi.org/10.1016/j.bbrc.2014.02.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24530395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24530395"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Alix A J Rouault, Abigail A Lee, Julien A Sebag "}, {"type": "b", "children": [{"type": "t", "text": "Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2017.09.008"}], "href": "https://doi.org/10.1016/j.bbamcr.2017.09.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28939058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28939058"}]}]}]}